Department of Diagnostic Imaging, the Warren Alpert Medical School of Brown University, Rhode Island Hospital, 593 Eddy St, Providence, RI 02903, USA.
Radiology. 2011 Apr;259(1):85-91. doi: 10.1148/radiol.10101009. Epub 2011 Feb 1.
To determine whether baseline screening breast magnetic resonance (MR) imaging studies have a higher rate of follow-up or biopsy recommendation than do studies with prior MR images available for comparison.
This was an institutional review board-approved, HIPAA-compliant, retrospective study. Informed consent was waived. Reports from 650 consecutive screening breast MR imaging examinations performed in women between September 2007 and December 2008 were reviewed. All examinations were performed by using the same protocol, and images were interpreted by the same radiologists. Presence of comparison studies, Breast Imaging Reporting and Data System (BI-RADS) category, and biopsy results were recorded. Data were analyzed by using the χ(2) test, the two-sample test of proportions, and the Fisher exact test.
Mean patient age was 51 years (range, 25-81 years). Of the baseline studies, findings in 31 of 307 (10.1%) were interpreted as BI-RADS category 3 and findings in 18 of 307 (5.9%) were interpreted as BI-RADS category 4 or 5. Of the examinations with findings classified as BI-RADS category 4 or 5, the results in two of 18 (11.1%) were positive for malignancy at biopsy. Of the examinations with prior MR images for comparison, findings in nine of 343 (2.6%) were interpreted as BI-RADS category 3 and findings in 16 of 343 (4.7%) were interpreted as BI-RADS category 4 or 5. Of the examinations with findings classified as BI-RADS category 4 or 5, the results in three of 16 (18.8%) were positive for malignancy at biopsy. The difference in the number of BI-RADS category 3 interpretations between the two groups was significant (P < .001), but there was no significant difference in BI-RADS category 4 or 5 interpretations or positive predictive values.
Baseline screening MR imaging was associated with a higher likelihood of recommendation for short-interval follow-up than was MR imaging with prior images for comparison.
确定基线筛查性乳腺磁共振(MR)成像研究是否比具有可比较的先前 MR 图像的研究具有更高的随访或活检推荐率。
这是一项经机构审查委员会批准、符合 HIPAA 规定的回顾性研究。免除了知情同意。回顾了 2007 年 9 月至 2008 年 12 月期间进行的 650 例连续筛查性乳腺 MR 成像检查的报告。所有检查均采用相同的方案进行,且图像由同一位放射科医生进行解读。记录了比较性研究的存在、乳腺影像报告和数据系统(BI-RADS)类别以及活检结果。使用卡方检验、两样本比例检验和 Fisher 精确检验对数据进行分析。
平均患者年龄为 51 岁(范围:25-81 岁)。在基线研究中,307 例中的 31 例(10.1%)的结果被解读为 BI-RADS 类别 3,而 307 例中的 18 例(5.9%)的结果被解读为 BI-RADS 类别 4 或 5。在结果为 BI-RADS 类别 4 或 5 的检查中,18 例中有 2 例(11.1%)活检结果为恶性。在具有先前比较性 MR 图像的检查中,343 例中有 9 例(2.6%)的结果被解读为 BI-RADS 类别 3,而 343 例中有 16 例(4.7%)的结果被解读为 BI-RADS 类别 4 或 5。在结果为 BI-RADS 类别 4 或 5 的检查中,16 例中有 3 例(18.8%)活检结果为恶性。两组之间 BI-RADS 类别 3 解读数量的差异具有统计学意义(P <.001),但 BI-RADS 类别 4 或 5 解读或阳性预测值无显著差异。
与具有先前比较性图像的 MR 成像相比,基线筛查性 MR 成像更有可能建议进行短期随访。